Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.58
-0.14 (-1.61%)
Last updated: Mar 3, 2026, 5:29 PM CET
Svas Biosana Market Cap
Svas Biosana has a market cap or net worth of €45.59 million as of March 3, 2026. Its market cap has increased by 5.57% in one year.
Market Cap
45.59M
Enterprise Value
90.52M
Revenue
134.95M
Ranking
n/a
PE Ratio
6.76
Stock Price
€8.58
Market Cap Chart
Since December 9, 2021, Svas Biosana's market cap has decreased from 81.14M to 45.59M, a decrease of -43.82%. That is a compound annual growth rate of -12.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 46.33M | 9.00% |
| Dec 30, 2025 | 42.51M | 10.91% |
| Dec 30, 2024 | 38.33M | -11.25% |
| Dec 29, 2023 | 43.19M | -20.87% |
| Dec 30, 2022 | 54.58M | -37.13% |
| Dec 30, 2021 | 86.80M | 6.97% |
| Dec 9, 2021 | 81.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 9.68B |
| DiaSorin | 3.83B |
| Amplifon | 2.73B |
| EL.En. | 1.12B |
| GPI S.p.A. | 491.10M |
| Health Italia | 55.91M |
| Talea Group | 40.74M |
| Farmacosmo | 19.79M |